MELISSA PAYNE: Open Payments
NPI 1124282884 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,622 in 127 payments from 29 companies in 2025. Trend: 2023 $2,985 · 2024 $2,622 · 2025 $2,622
Food & beverage: $2,622
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $485 |
| AstraZeneca Pharmaceuticals LP | 5 | $235 |
| UCB, Inc. | 7 | $193 |
| Lilly USA, LLC | 11 | $175 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $171 |
| GlaxoSmithKline, LLC. | 10 | $164 |
| BioCryst US Sales Co., LLC | 7 | $142 |
| Abbott Laboratories | 5 | $115 |
| Mallinckrodt Hospital Products Inc. | 4 | $108 |
| Novo Nordisk Inc | 5 | $94 |
Products named: JARDIANCE, BREZTRI, Bimzelx, VRAYLAR, RINVOQ, ORLADEYO, SKYRIZI, FREESTYLE LIBRE 3.
Industry payments across NY — which companies pay providers there.
